IM32 Sigma-AldrichAnti-TIMP-1 (Ab-1) Mouse mAb (7-6C1)
This Anti-TIMP-1 (Ab-1) Mouse mAb (7-6C1) is validated for use in Immunoblotting, Immunocytochemistry, Paraffin Sections for the detection of TIMP-1 (Ab-1).
More>> This Anti-TIMP-1 (Ab-1) Mouse mAb (7-6C1) is validated for use in Immunoblotting, Immunocytochemistry, Paraffin Sections for the detection of TIMP-1 (Ab-1). Less<<Synonyme: Anti-Tissue Inhibitor of Metalloproteinase-1
Empfohlene Produkte
Übersicht
Replacement Information |
---|
Key Spec Table
Species Reactivity | Host | Antibody Type |
---|---|---|
B, H, R | M | Monoclonal Antibody |
Preis & Verfügbarkeit
Bestellnummer | Verfügbarkeit | Verpackung | St./Pkg. | Preis | Menge | |
---|---|---|---|---|---|---|
IM32-100UG |
|
Kst.-Ampulle | 100 μg |
|
— |
Product Information | |
---|---|
Declaration | Manufactured by Daiichi Fine Chemical Co., Ltd. Not available for sale in Japan. |
Form | Liquid |
Formulation | In 100 mM sodium phosphate buffer, 0.1% BSA, pH 7.0. |
Positive control | rTIMP-1 Protein (Cat. Nos. PF019 or PF020) |
Preservative | ≤0.1% sodium azide |
Quality Level | MQ100 |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Bestellnummer | GTIN |
IM32-100UG | 07790788053765 |
Documentation
Anti-TIMP-1 (Ab-1) Mouse mAb (7-6C1) SDB
Titel |
---|
Anti-TIMP-1 (Ab-1) Mouse mAb (7-6C1) Analysenzertifikate
Titel | Chargennummer |
---|---|
IM32 |
Literatur
Übersicht |
---|
Fujimoto, N. and Iwata, K., 1994. Connective Tissue 26, 237. Cottam, D. W. and Rees, R. C., 1993. Intl. J. Oncol. 2, 861. Stetler-Stevenson, W. G., et al. 1993. FASEB J. 7, 1434. Woessner, J. F., 1991. FASEB J. 5, 2145. Liotta, L. A. and Stetler-Stevenson, W. G. 1990. in Seminars in Cancer Biology ed. M. M. Gottesman. Vol. 99-106. |